144 related articles for article (PubMed ID: 12576149)
1. Potentiation of amphetamine-induced changes in dopamine and 5-HT by a 5-HT(6) receptor antagonist.
Dawson LA; Nguyen HQ; Li P
Brain Res Bull; 2003 Feb; 59(6):513-21. PubMed ID: 12576149
[TBL] [Abstract][Full Text] [Related]
2. The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus.
Dawson LA; Nguyen HQ; Li P
Neuropsychopharmacology; 2001 Nov; 25(5):662-8. PubMed ID: 11682249
[TBL] [Abstract][Full Text] [Related]
3. In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate.
Dawson LA; Nguyen HQ; Li P
Br J Pharmacol; 2000 May; 130(1):23-6. PubMed ID: 10780993
[TBL] [Abstract][Full Text] [Related]
4. Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.
Dawson LA; Li P
J Neural Transm (Vienna); 2003 Jun; 110(6):577-90. PubMed ID: 12768354
[TBL] [Abstract][Full Text] [Related]
5. 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.
Porras G; Di Matteo V; Fracasso C; Lucas G; De Deurwaerdère P; Caccia S; Esposito E; Spampinato U
Neuropsychopharmacology; 2002 Mar; 26(3):311-24. PubMed ID: 11850146
[TBL] [Abstract][Full Text] [Related]
6. Central serotonin4 receptors selectively regulate the impulse-dependent exocytosis of dopamine in the rat striatum: in vivo studies with morphine, amphetamine and cocaine.
Porras G; Di Matteo V; De Deurwaerdère P; Esposito E; Spampinato U
Neuropharmacology; 2002 Dec; 43(7):1099-109. PubMed ID: 12504916
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic regulation of the serotonergic raphe-striatal pathway: microdialysis studies in freely moving rats.
Ferré S; Cortés R; Artigas F
J Neurosci; 1994 Aug; 14(8):4839-46. PubMed ID: 7519257
[TBL] [Abstract][Full Text] [Related]
8. 5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex.
Lacroix LP; Dawson LA; Hagan JJ; Heidbreder CA
Synapse; 2004 Feb; 51(2):158-64. PubMed ID: 14618683
[TBL] [Abstract][Full Text] [Related]
9. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
Li Z; Huang M; Prus AJ; Dai J; Meltzer HY
Brain Res; 2007 Feb; 1134(1):70-8. PubMed ID: 17207474
[TBL] [Abstract][Full Text] [Related]
10. In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.
Navailles S; De Deurwaerdère P; Porras G; Spampinato U
Neuropsychopharmacology; 2004 Feb; 29(2):319-26. PubMed ID: 14560323
[TBL] [Abstract][Full Text] [Related]
11. 5-HT(6) receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine.
Frantz KJ; Hansson KJ; Stouffer DG; Parsons LH
Neuropharmacology; 2002 Feb; 42(2):170-80. PubMed ID: 11804613
[TBL] [Abstract][Full Text] [Related]
12. Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum.
Lucas G; Spampinato U
J Neurochem; 2000 Feb; 74(2):693-701. PubMed ID: 10646521
[TBL] [Abstract][Full Text] [Related]
13. Dopamine depletion abolishes apomorphine- and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats: a microdialysis study.
Balcioglu A; Zhang K; Tarazi FI
Neuroscience; 2003; 119(4):1045-53. PubMed ID: 12831863
[TBL] [Abstract][Full Text] [Related]
14. Tph2 gene deletion enhances amphetamine-induced hypermotility: effect of 5-HT restoration and role of striatal noradrenaline release.
Carli M; Kostoula C; Sacchetti G; Mainolfi P; Anastasia A; Villani C; Invernizzi RW
J Neurochem; 2015 Nov; 135(4):674-85. PubMed ID: 26259827
[TBL] [Abstract][Full Text] [Related]
15. Serotonin 5-HT(2) receptor stimulation of dopamine release in the posterior but not anterior nucleus accumbens of the rat.
Bowers BJ; Henry MB; Thielen RJ; McBride WJ
J Neurochem; 2000 Oct; 75(4):1625-33. PubMed ID: 10987844
[TBL] [Abstract][Full Text] [Related]
16. Modulation of dopamine release by striatal 5-HT2C receptors.
Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA
Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911
[TBL] [Abstract][Full Text] [Related]
17. Effect of metyrapone on the fluoxetine-induced change in extracellular dopamine, serotonin and their metabolites in the rat frontal cortex.
Rogóż Z; Gołembiowska K
Pharmacol Rep; 2010; 62(6):1015-22. PubMed ID: 21273658
[TBL] [Abstract][Full Text] [Related]
18. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
[TBL] [Abstract][Full Text] [Related]
19. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
Ichikawa J; Meltzer HY
Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
[TBL] [Abstract][Full Text] [Related]
20. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
Ichikawa J; Meltzer HY
J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
